Also trades as: BDMS.BK (SET) · $vol 40M · BDUUY (OTC) · $vol 0M · BDULF (OTC) · $vol 0M · BDUUF (OTC) · $vol 0M
BDMS-R.BK SET
Bangkok Dusit Medical Services Public Company Limited
1W: -5.5%
1M: -5.7%
3M: -3.0%
YTD: -8.6%
1Y: -15.2%
3Y: -27.4%
5Y: -6.3%
฿19.00 ($0.57)
+0.00 (+0.00%)
Weekly Expected Move ±3.2%
฿18
฿18
฿19
฿20
฿20
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$23.4B
+2.1% ▲
5Y CAGR: +15.0%
Capital Expenditures
$10.4B
+10.8% ▲
5Y CAGR: +9.4%
Free Cash Flow
$13.0B
+15.6% ▲
5Y CAGR: +21.0%
Dividends Paid
$11.9B
-7.2% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1.0B
-144.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $10.6B | $16.5B | $18.7B | $20.3B | $15.8B |
| Depreciation & Amort. | $6.3B | $5.9B | $5.8B | $6.1B | $6.8B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$349M | -$138M | -$728M | -$231M | -$953M |
| Other Non-Cash Items | -$2.0B | -$2.0B | -$3.0B | -$3.3B | $1.7B |
| Operating Cash Flow | $14.6B | $20.3B | $20.8B | $23.0B | $23.4B |
| — Investing Activities — | |||||
| Capital Expenditures | -$4.4B | -$5.1B | -$8.3B | -$10.7B | -$11.3B |
| Acquisitions (Net) | $21M | $863K | -$480M | $0 | $379M |
| Investment Purchases | -$493M | -$1.1B | -$247M | -$257M | -$230M |
| Investment Sales | $20M | $233M | $719M | $388M | $446M |
| Other Investing | $60M | $52M | $561M | -$786M | $0 |
| Investing Cash Flow | -$4.8B | -$5.9B | -$7.8B | -$11.4B | -$10.7B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$5.6B | -$2.7B | -$6.3B | -$558M | -$1.0B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$12.7B | -$7.9B | -$10.3B | -$11.1B | -$11.9B |
| Other Financing | -$187M | -$2.0B | -$1.2B | -$292M | -$774M |
| Financing Cash Flow | -$18.5B | -$12.6B | -$17.9B | -$12.0B | -$13.7B |
| Net Change in Cash | -$8.7B | $1.7B | -$4.9B | -$422M | -$1.0B |
| Cash End of Period | $10.9B | $12.7B | $7.8B | $7.4B | $6.3B |
| Free Cash Flow | $10.2B | $15.2B | $12.5B | $11.3B | $13.0B |